TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 133.1M
Gross Profit 97.7M 73.40%
Operating Income 8.0M 6.05%
Net Income -11.8M -8.89%

Balance Sheet Metrics

Total Assets 845.8M
Total Liabilities 538.3M
Shareholders Equity 307.5M
Debt to Equity 1.75

Cash Flow Metrics

Revenue & Profitability Trend

Centennial Surgical Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i535.2M511.9M526.6M444.3M369.3M
Cost of Goods Sold i172.3M173.0M202.3M198.0M105.9M
Gross Profit i362.9M338.9M324.3M246.2M263.5M
Gross Margin % i67.8%66.2%61.6%55.4%71.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-14.9M15.8M10.6M14.5M
Other Operating Expenses i181.7M158.9M152.3M82.8M97.8M
Total Operating Expenses i181.7M173.8M168.1M93.4M112.3M
Operating Income i20.1M37.6M31.0M29.6M35.5M
Operating Margin % i3.8%7.4%5.9%6.7%9.6%
Non-Operating Items
Interest Income i-803.0K111.0K83.0K59.0K
Interest Expense i37.5M9.3M7.0M7.6M9.7M
Other Non-Operating Income-----
Pre-tax Income i-16.2M12.7M14.6M10.7M15.3M
Income Tax i-1.5M1.4M5.8M4.5M5.7M
Effective Tax Rate % i0.0%10.9%39.4%41.6%37.1%
Net Income i-14.6M11.3M8.9M6.3M9.6M
Net Margin % i-2.7%2.2%1.7%1.4%2.6%
Key Metrics
EBITDA i63.8M35.9M34.6M33.7M40.5M
EPS (Basic) i-₹3.11₹2.43₹1.72₹2.64
EPS (Diluted) i-₹3.11₹2.43₹1.72₹2.64
Basic Shares Outstanding i-3648300364830036483003648300
Diluted Shares Outstanding i-3648300364830036483003648300

Income Statement Trend

Centennial Surgical Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i2.2M6.8M3.3M2.6M5.4M
Short-term Investments i---5.0K69.0K
Accounts Receivable i184.0M188.0M205.9M195.3M224.0M
Inventory i434.8M425.2M372.4M322.6M362.3M
Other Current Assets8.7M1.0K12.0M-1.0K4.6M
Total Current Assets i629.6M653.2M593.7M532.7M606.1M
Non-Current Assets
Property, Plant & Equipment i199.8M127.7M64.6M76.0M89.7M
Goodwill i42.0K52.0K43.0K34.0K70.0K
Intangible Assets i42.0K52.0K43.0K34.0K70.0K
Long-term Investments-----
Other Non-Current Assets2.6M-1.0K1.4M1.0K1.4M
Total Non-Current Assets i216.2M138.3M70.3M80.7M94.3M
Total Assets i845.8M791.5M664.0M613.4M700.4M
Liabilities
Current Liabilities
Accounts Payable i71.7M97.1M122.3M85.6M105.8M
Short-term Debt i122.6M153.0M106.3M99.1M128.2M
Current Portion of Long-term Debt-----
Other Current Liabilities62.2M28.8M28.8M28.8M4.4M
Total Current Liabilities i318.3M328.5M290.7M242.0M315.0M
Non-Current Liabilities
Long-term Debt i-123.0M43.6M50.0M68.8M
Deferred Tax Liabilities i01.2M2.3M2.2M1.7M
Other Non-Current Liabilities-1.0K-2.0K-1.0K-2.0K-
Total Non-Current Liabilities i220.0M140.8M62.4M69.4M89.7M
Total Liabilities i538.3M469.3M353.2M311.4M404.7M
Equity
Common Stock i54.2M54.2M54.2M54.2M54.2M
Retained Earnings i-267.9M256.6M247.7M241.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i307.5M322.2M310.8M302.0M295.7M
Key Metrics
Total Debt i122.6M276.0M149.8M149.1M197.0M
Working Capital i311.3M324.7M303.0M290.7M291.1M

Balance Sheet Composition

Centennial Surgical Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-16.2M12.7M14.6M10.7M15.3M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i16.1M-59.2M-61.4M69.5M-26.3M
Operating Cash Flow i37.0M-22.6M-30.3M99.1M9.1M
Investing Activities
Capital Expenditures i-114.7M-77.0M-1.6M-1.6M-8.4M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i00000
Investing Cash Flow i-114.7M-77.0M-1.6M-1.7M-8.4M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i----0
Debt Repayment i-21.9M--16.6M-29.7M0
Financing Cash Flow i-43.7M45.3M-10.5M-59.5M7.5M
Free Cash Flow i56.0M-14.8M11.3M45.9M11.3M
Net Change in Cash i-121.4M-54.3M-42.4M37.9M8.2M

Cash Flow Trend

Centennial Surgical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 2,482.50
Price to Book 1.82
Price to Sales 1.04

Profitability Ratios

Profit Margin -2.74%
Operating Margin 6.05%
Return on Equity -4.65%
Return on Assets 1.53%

Financial Health

Current Ratio 1.98
Debt to Equity 108.97
Beta 0.49

Per Share Data

EPS (TTM) ₹-4.01
Book Value per Share ₹84.30
Revenue per Share ₹146.69

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
csurgsu558.2M2,482.501.82-4.65%-2.74%108.97
Poly Medicure 195.3B56.517.1715.99%20.28%6.52
Dr Agarwal's Health 140.4B625.567.456.61%4.88%49.87
Laxmi Dental 21.8B64.4210.3325.70%13.29%9.35
Tarsons Products 19.9B66.743.154.79%7.59%53.82
Prevest Denpro 6.7B36.866.3518.70%28.81%0.00

Financial data is updated regularly. All figures are in the company's reporting currency.